ORPHA:854
Non-malignant and non-cirrhotic portal vein thrombosis
Also known as: Non-cirrhotic and non-tumoral portal vein thrombosis · Non-malignant non-cirrhotic PVT
Publications
106
60.6th percentile
Trials
0
Interventional, condition-specific
Researchers
580
Distinct authors in sample
Gene link
—
Readiness
1/6
Stages with a signal
Clinical definition (Orphanet)
Portal vein thrombosis (PVT) is associated with acute (recent) or chronic (long-standing) thrombosis of the portal system.
How rare: 1-9 / 100 000 — about one to nine people per hundred thousand.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0019431
- UMLS:C6012228
Additional Mondo synonyms (1)
non-cirrhotic portal vein thrombosis
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
1/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
106 matched papers (72 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
106
106 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
106 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
72 in the last 10 years · high confidence · 60.6th percentile (publications denominator)
Phrase hits: 106 · MeSH hits: 0
Who's working on it?
580
Distinct author names in 106 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Janssen HL6 papers · 2015
Department of Gastroenterology and Hepatology, University Hospital Rotterdam, The Netherlands. devlaming@mdl.arz.nl
Papers in Europe PMC - 02Hernández-Gea V5 papers · 2026
Centro de Investigación Biomédica en Enfermedades Hepáticas y Digestivas, CIBERehd, Instituto de Salud Carlos III, España; Laboratorio de Hemodinámica Hepática, Servicio de Hepatología, Hospital Clínic, IDIBAPS, Barcelona, España.
Papers in Europe PMC - 03Turon F5 papers · 2026
Hepatic Hemodynamic Laboratory, Liver Unit, Institut de Malalties Digestives, IDIBAPS and Ciberehd, Barcelona, Spain.
Papers in Europe PMC - 04Baiges A4 papers · 2026
Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBEREHD), European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Institut de Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Papers in Europe PMC - 05Bureau C4 papers · 2026
Service d'hépato-gastro-entérologie CHU Toulouse Hôpital Purpan et Université Paul Sabatier, Toulouse, France. Electronic address: bureau.c@chu-toulouse.fr.
Papers in Europe PMC - 06Albillos A3 papers · 2026
Servicio de Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá, Madrid, España; Centro de Investigación Biomédica en Enfermedades Hepáticas y Digestivas, CIBERehd, Instituto de Salud Carlos III, España.
Papers in Europe PMC - 07Bosch J3 papers · 2023
Hepatology, Inselspital, University of Berne, Switzerland; Hepatic Hemodynamic Laboratory, Liver Unit Hospital Cliníc, IDIBAPS and Ciberehd, Barcelona, Spain.
Papers in Europe PMC - 08Crespo J3 papers · 2023
Digestive Disease Department, Marqués de Valdecilla University Hospital, Cantabria University, Av. Valdecilla s/n, 39008 Santander, Spain.
Papers in Europe PMC - 09D'Antiga L3 papers · 2025
Paediatric Liver, GI and Transplantation, Hospital Papa Giovanni XXIII Bergamo, Bergamo, Italy. Electronic address: ldantiga@asst-pg23.it.
Papers in Europe PMC - 10Di Giorgio A3 papers · 2025
Paediatric Liver, GI and Transplantation, Hospital Papa Giovanni XXIII Bergamo, Bergamo, Italy.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name. 1 observational study did — shown below because natural-history and cohort work can be an important step toward a trial.
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
high confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Observational and natural-history studies
1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
None of the matched observational studies is currently listed as recruiting.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Non-malignant and non-cirrhotic portal vein thrombosis" OR "Non-cirrhotic and non-tumoral portal vein thrombosis" OR "Non-malignant non-cirrhotic PVT" OR "non-cirrhotic portal vein thrombosis"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Non-malignant and non-cirrhotic portal vein thrombosis" OR "Non-cirrhotic and non-tumoral portal vein thrombosis" OR "Non-malignant non-cirrhotic PVT" OR "non-cirrhotic portal vein thrombosis"
Study-type breakdown: 0 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T15:39:36.667Z